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generic utilization 72.2% of the claims (range=66.1%-84.8%). The average price of 
generic drug was $17.44 (range=$6.25-$29.12), while the average price of brand 
drugs was $217.07 (range=$105.63-$357.51). The average pharmacy dispensing fee 
was $4.51±$2.03 for generics and $4.26±$2.03 for brands (range for both=$1.75-
$11.50). The ingredient cost was estimated using average wholesaler price (AWP) 
(n=25), wholesaler acquisition cost (WAC, n=11) and combination AWP/WAC 
(n=10). We found no statistical significant relationship between the number of 
claims or the total state expenditures, and the dispensing fee or ingredient cost. 
CONCLUSIONS: Dispensing fees and ingredient cost varied among the different 
states’ Medicaid programs. Those differences were not related to the total 
utilization and expenditures of the state programs. Appropriate reimbursement 
and dispensing fee policies encouraging generic utilization could result in 
substantial saving for the Medicaid program.  
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OBJECTIVES: As the health care safety net continues to grow in both depth and 
breadth, the provider payment system will play an increasing role in the 
resource allocation of health care in China. This paper is intended to assess the 
primary effects of payment reform of capitation experiment and the 
supplementary open enrollment policy in Changde city, China. METHODS: In 
October 2007, Changde employed a capitation approach to pay for health care 
under the Urban Resident Basic Medical Insurance (URBMI), while the fee-for-
service approach was still used by the Urban Employee Basic Medical Insurance 
(UEBMI) in the city and other programs as well. Using the national URBMI 
Household Panel Survey from 2008-2010, we conducted a set of difference-in-
difference (DD) models to assess the capitation policy effect on cost and 
utilization outcomes while controlling for other differences between Changde 
and other cities. RESULTS: The study finds the payment reform to reduce its 
inpatient out-of-pocket cost by 19.7%, out-of-pocket ratio by 9.5%, and length of 
stay by 17.5%. The total inpatient cost, drug cost ratio, treatment effect, and 
patient satisfaction showed little difference between FFS and capitation models. 
The robust tests find the relatively poor health subsample present a similar 
pattern with the results based on the full sample; as for the population cohort 
with good and very good self-rated health conditions, the payment reform in 
Changde has little impact on either providers or patients. CONCLUSIONS: We 
conclude that the payment reform in Changde led to an decrease in the financial 
burden of patients for inpatient care and improve hospital efficiency, without 
compromising quality of care. The total cost measures remain no change 
between capitation and FFS settings, which can be research topics for further 
studies concerning the long term effect of capitation approaches.  
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OBJECTIVES: To investigate treatment patterns of glaucoma and persistence to 
therapy in a large health organization (HMO) in Israel. METHODS: A retrospective 
cohort study, conducted using the electronic medical databases of Maccabi 
Healthcare Services, a 2 million member HMO in Israel. The study population 
consisted of all patients who were newly diagnosed with glaucoma between 2003 
and 2010 at MHS. Collected data included personal characteristics and 
demographics, relevant surgical procedures, prescribed and dispensed anti-
glaucoma medications, and caregiver characteristics. We investigated quality of 
care indices including routine ophthalmologist follow up, performance of 
tonometry tests, as well as persistence to treatment by drug type. Persistence 
was analyzed by proportion of days covered by drugs during follow up time, 
ignoring overlaps due to overuse and simultaneous combination of several types 
of eye drops. RESULTS: A total of 11,512 incident glaucoma patients, who were 
diagnosed between 2003 and 2010 were identified. One quarter of these patients 
remained naïve through the follow-up period, additional 20% were non-adherent 
with therapy (covered less than 20% of the follow up time), and only 13% 
exhibited high persistence (covered at least 80% of the follow-up period). The 
most common physician was ophthalmologist both at treatment initiation (70% 
of initial prescriptions were ophthalmologist vs. 7% by general practitioner) and 
ongoing prescriptions (48% ophthalmologist vs. 22% by general practitioner). 
CONCLUSIONS: The current study demonstrates the potential use of automated 
medical databases to characterize treatment patterns of glaucoma, illustrate the 
great variety of drug therapies, and describe adherence to treatment in the 
community. The increased comorbidity and mortality among these patients has 
important implication for health authorities for prevention and delivery of 
health-care services.  
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OBJECTIVES: To investigate outpatients' knowledge, attitude and awareness 
on medication and analyze the influential factors. METHODS: A total of 711 
outpatients who consented to participate the survey were recruited from 306 
Hospital of PLA in Beijing between 2009-2012. The self-administered question-
naire was composed of XX questions. Multiple linear regressions were run to 
explore the influential factors. Data were analyzed using STATA v11.0. 
RESULTS: The outpatients investigated showed a poor cognition on rational 
drug use. 84.8% of the patients would stop taking drugs by themselves. 60.1% 
of the patients were aware of adverse drug reactions. Age, urban-rural 
difference, knowledge of medication, and health status have different degrees 
of influence on the medication behavior and medication willingness of 
patients, while family income and health insurance have little influence. 
Information provided by the patients was compared with the prescriptions. 
CONCLUSIONS: These results suggest that outpatients in China had much 
misunderstanding about drug use. Patients’ education regarding rational  
drug use is an important issue and deserves urgent improvement. KEY 
WORDS: Outpatients; Cognition; Determin-ants; Rational use of drug; Self-
medication.  
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OBJECTIVES: To determine patient demographics and treatment patterns  
in patients with Crohn’s Disease (CD) who initiated biologic treatment with a 
TNF antagonist (infliximab or adalimumab). METHODS: Patients ≥ 18 years with 
CD (ICD-9:555.X) who initiated a TNF antagonist between January 2007 and  
December 2008 were identified from the US IMPACT health insurance claims 
data-base. Two cohorts were identified; those who received CD related surgery 
(CDSURG) within a 24-month follow-up and those who did not (CDNon-SURG). 
Patients continuously enrolled for medical and pharmacy benefits during 6 
months prior to their first TNF antagonist claim (index claim). RESULTS: A  
total of 812 individuals with CD were followed over a 24-month period, of which 
92% were CDNon-SURG and 8% were CDSURG patients. The majority of patients 
(89%) were 18 to 54 years old with a higher portion of CDSURG patients in the 18-
34 age range. CDSURG included younger patients (mean age: 37 yrs) and a lower 
percent of females (48%) compared to CDNon-SURG (41 yrs; 59% female). 
CDSURG patients had higher hospitalization rates (38%) and incurred more 
health care expenditures ($15,112) during baseline compared to CDNon-SURG 
patients (23%; $13,400). During the last 6 months of follow-up, the percentage of 
CDSURG patients on biologics dropped to 44%; of the 56% in CDSURG who 
discontinued biologics, 31% received no treatment. In contrast, the percentage of 
CDNon-SURG patients continuing biologics decreased to 67% with 37% remaining 
on a “biologic only.” CONCLUSIONS: Most CD patients (92%) initiated on biologics 
did not require surgery, however about one third stopped TNF antagonist 
treatment over 24 months. Although 8% of CD patients underwent surgery, they 
incurred high direct and indirect costs even prior to surgery. Even with 
availability of TNF antagonists, due to high discontinuation rate, there is an 
unmet need of effective CD treatment options that may delay or prevent disease 
progression.  
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OBJECTIVES: To identify patient demographics and treatment use patterns in 
patients with Ulcerative Colitis (UC) who initiated biologic treatment with 
infliximab in a managed care setting. METHODS: Patients with UC (ICD-9 code 
556.X) who initiated infliximab between January 2007 and December 2008 were 
identified from the US IMPACT health insurance claims database. Two cohorts 
were identified based on whether they received UC related surgery (UCSURG) or 
did not receive a UC related surgery (UCNon-SURG) within a 24 month follow-up. 
All patients were continuously enrolled for both medical and pharmacy benefits 
during the 6 months prior to their first infliximab claim (index claim) and 24 
months post index claim. RESULTS: A total of 264 individuals with UC were 
followed over 24-months, of which 84% did not receive surgery (UCNon-SURG) 
and 16% underwent surgery (UCSURG). In both cohorts, mean age was 42 years 
and 45% were women. The majority of patients (80%) were 18 to 54 years old 
with a higher proportion of UCSURG patients in the 35-44 year group range. 
During the 6-month baseline period, UCSURG patients had higher hospitalization 
rates (40%) and incurred more health care expenditures ($17,217) than UCNon-
SURG (22%; $11,774). In the 24 month follow-up, 60% of patients within UCSURG 
underwent surgery during the first year following their index claim. Seventy 
percent of UCNon-SURG patients continued biologics with 34% remaining  
on “biologic only” compared to UCSURG, where 70% had no treatment. 
CONCLUSIONS: Most UC patients (84%) initiated on infliximab did not require 
surgery and continued biologic treatment (70%) over 24 months. Additional 
research is needed to further understand reasons for discontinuation of  
biologic treatment. Although 16% of UC patients underwent surgery, they 
incurred high direct and indirect costs even prior to surgery. There is an unmet 
need of effective UC treatment options that may delay or prevent disease 
progression.  
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OBJECTIVES: To analyze the effects of pre-existing substance use on 
complications in Medicare elderly prostate cancer patients treated with radical 
prostatectomy. METHODS: We used SEER-Medicare linked database to identify 
men diagnosed with prostate cancer between 2000 and 2009 and treated with 
radical prostatectomy, we identified those with a pre-existing diagnosis of 
substance use (ICD-9 codes: Alcohol dependence syndrome-303.xx, Drug 
dependence 304.xx and Non-dependent abuse of drugs 305.xx). Seven mutually 
exclusive complications related to radical prostatectomy (respiratory, cardiac, 
vascular, wound/bleeding, genitourinary, miscellaneous medical and surgical) 
were identified in the sixty days post-radical prostatectomy. Number of 
complications is modeled as a factor of pre-existing substance use, after 
controlling for socio-demographic and clinical characteristics using Poisson 
regression. We also analyzed the effects of specific types of substance use on 
complications. RESULTS: Of the 33,148 men treated with radical prostatectomy, 
6.01% had a pre-existing diagnosis of substance use. Complications within sixty 
days of radical prostatectomy were higher for those with pre-existing substance 
use (OR=1.34; CI=1.25-1.44), compared to those without. In particular, drug 
dependence had the highest impact on complications (OR= 4.12; CI=2.86-5.94), 
compared to alcohol and non-dependent abuse of drugs. CONCLUSIONS: 
Complications related to radical prostatectomy are significantly affected by pre-
existing substance use in elderly prostate cancer patients. Also, this affect varies 
by type of substance use. Complications are an important indicator of quality of 
care and thus, our results emphasize the need to for early diagnosis and effective 
treatment of substance use, especially drug dependence, in elderly prostate 
cancer patients.  
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OBJECTIVES: To analyze association between substance abuse and quality of 
care in Medicare fee-for-service elderly with non-muscle invasive bladder 
cancer. METHODS: Retrospective case control design using SEER-Medicare 
databases. Non-muscle invasive bladder cancer patients diagnosed between 
2001-2004 were identified. From this, we identified those with and without a 
diagnosis of substance abuse (ICD-9 codes: Alcohol dependence syndrome-
303.xx, Drug dependence 304.xx and Non-dependent abuse of drugs 305.xx). The 
groups were retrospectively followed for one year pre and five years post 
diagnosis. Effect of substance abuse on quality of care (ER, inpatient and 
outpatient visits) and cost was analyzed after adjusting for clinical and 
demographic variables. To compute incremental cost of non-muscle invasive 
bladder cancer, cancer free controls were selected (matched by age, gender, 
ethnicity) from Medicare. Poisson regression and GLM log-link models were used 
to analyze the association of substance abuse with health resource utilization 
and cost. Propensity score approach was used to minimize bias. RESULTS: A 
total of 33,396 patients with non-muscle invasive bladder between 2001 and 2004 
we identified. Average age was 76.7 years (std 7.2), 88% were white, 73% were 
male, and 61% were married. Substance abuse prevalence was 15.96%. Compared 
to those no substance abuse, the substance abuse group had higher odds of ER 
(OR=1.56, CI=1.48-1.63), inpatient (OR=1.17, CI=1.14-1.19) and outpatient visits 
(OR=1.37, CI=1.35-1.39) in the one year post-dignosis period. Compared to no 
substance abuse group, the substance abuse group had higher total cost.We 
observed comparable results in the five year follow-up period. CONCLUSIONS: 
Substance abuse appears to affect quality of care and cost among elderly with 
non-muscle invasive bladder cancer. Further research is necessary to study the 
impact of interventions, early diagnosis and treatment of substance abuse in 
elderly bladder cancer patients to improve quality of care through care 
coordination.  
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OBJECTIVES: Reducing avoidable hospitalizations is a major target of recent 
health care reform efforts. Increasing the supply of primary care providers has 
been proposed as one way to reduce hospitalizations. There is little empirical 
evidence, however, that has linked increased availability of primary care to 
reduced hospitalizations. Further, it is unknown if primary care availability has 
the same effect on hospitalization rates for the uninsured as the insured. The 
purpose of this study is to examine the association between primary care 
availability, all-cause hospitalizations, and admissions for three common types 
among nonelderly adults (ambulatory care sensitive conditions, mental health 
and substance abuse, and mandatory admissions). METHODS: Using data from 
the 2009 Healthcare Cost and Utilization Project (HCUP) State Inpatient Data-
bases (SID) we examined variations in inpatient hospitalizations between the 
insured and uninsured across Core Based Statistical Areas (CBSAs) in 44 states. 
We also explored the association between primary care availability and hospital 
use by insurance status while controlling for patient, population and market 
factors using a broad definition of primary care. Poisson regression models were 
used to estimate the relationship between primary care availability and the rate 
of hospitalizations by insurance status. RESULTS: Primary care supply is 
generally linked to lower hospitalizations across conditions. Areas with more 
community health centers and rural health clinics were linked to greater 
hospital use among the uninsured. CONCLUSIONS: The findings from our  
study highlight some of the complexities and nuanced relationship between the 
supply of primary care providers and hospitalizations by insurance status.  
The availability of primary care alone may not be enough to reduce the 
differences in hospital use. Policies that take into consideration the availability 
of primary care in addition to issues of accessibility, appropriateness, and 
effectiveness may mitigate differences in hospital utilization between 
populations.  
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OBJECTIVES: Numerous studies have revealed that many health care systems 
can be characterized by ineffectiveness and inefficiency. One approach to 
improve the quality of health care that has become increasingly popular is Pay-
for-Performance (P4P). P4P links payments to performance on predefined quality 
measures. To date, P4P has become a part of several health care systems. How-
ever, previous published studies evaluating P4P programs show that the effects 
are heterogenic and conclude that P4P has the potential to enhance quality of 
health care. Therefore, this analysis aims at assessing P4P effectiveness and 
success factors of prospective programs. METHODS: A systematic literature 
search on P4P-reviews published between 2000 and 2012 was conducted in 
PubMed and Cochrane Database of Systematic Reviews. The literature searches 
provided 297 citations for inclusion. After different exclusion steps (title, 
abstract, and full-text screening) and an additional hand search, nine reviews 
were included. The literature search is based on the recommendations of 
Cochrane Collaboration and the Institute for Quality and Efficiency in Health 
care. The methodological quality of each review was assed using the AMSTAR-
checklist. RESULTS: In sum, reviews analyse 75 different primary studies. Most 
of the studies focus on the US (47) and the UK (19). In 60 evaluations, primary 
studies are categorised as having positive effects. P4P is linked to negative 
results in 16 studies. Nevertheless, in 61 cases the results are assessed to have 
positive and negative effects. Success factors of P4P programs contain of three 
key issues: (1) What to incentivize: Dimensions of performance; (2) Whom to 
incentivize: Individuals or groups; (3) How to incentivize: Rewards or penalties/ 
incentive size/absolute or relative performance/frequency and duration. 
CONCLUSIONS: Reviews confirm that P4P can improve quality of care, though 
not always. Therefore, financial incentives have to be designed and 
implemented carefully. Better-designed studies are needed to determine success 
factors for quality improvement.  
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OBJECTIVES: Emergency hospital readmissions are costly to the health care 
system. Identifying high-risk patients and targeting intensive post-discharge 
interventions may help reduce readmissions. Thus, this study aims to develop 
and validate a predictive model to score patients’ risk of emergency hospital 
readmission in an acute hospital in Singapore. METHODS: In a retrospective 
cohort study, data were collected for medical patients discharged from 
Alexandra Hospital between August 2011 and December 2011. We identified 
potential risk factors based on the variables used in the “LACE” index and 
“HARRPE” model. Using a split-sample design, we constructed logistic regression 
models to predict readmission or death within 30 days. A risk index was then 
developed to score the readmission risk using the methods described by Sullivan 
et al. The C-statistic was used to measure discriminative ability and the Hosmer–
Lemeshow goodness-of-fit test was used for calibration. RESULTS: Of 3175 
patient discharges, 20.3% were readmitted to hospital or died within 30 days  
of discharge. The variables independently associated with the outcome included 
admissions in previous one year, number of comorbidities, emergency de-
partment visits in previous six months and length of stay. The risk score was 
discriminative (C-statistics 0.763, 95% CI: 0.737-0.788) and accurate (Hosmer–
Lemeshow statistic 11.46, p=0.177) at predicting outcome risk. The expected risk 
ranged from 4.3% (score 0) to 65.3% (score 18). The optimal cut-off score that 
maximized sensitivity and specificity was six. High-risk patients (score ≥6) 
accounted for 32.0% of the sample, and had four times the risk of readmission or 
death within 30 days compared with other patients (score <6). CONCLUSIONS: 
Our findings provide an evidence-based tool to enable the early identification of 
high-risk patients in Singapore. This can be embedded in electronic medical 
records to alert clinicians of high-risk patients who may require intensive post-
discharge intervention to avoid readmission.  
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OBJECTIVES: Home care (nursing) was introduced into the Hungarian basic 
health insurance package in 1996. The aim of our study is to analyze  
